Kinaxis (TSE:KXS - Get Free Report) had its price objective lifted by TD Securities from C$190.00 to C$225.00 in a research report issued to clients and investors on Friday,BayStreet.CA reports. The firm presently has a "buy" rating on the stock. TD Securities' target price would suggest a potential upside of 22.59% from the stock's previous close.
Other analysts have also issued reports about the stock. Scotiabank lifted their price target on shares of Kinaxis from C$225.00 to C$240.00 and gave the stock an "outperform" rating in a research note on Friday, August 8th. Royal Bank Of Canada raised their price target on Kinaxis from C$225.00 to C$235.00 in a research note on Friday, August 8th. Finally, Stifel Nicolaus boosted their target price on shares of Kinaxis from C$225.00 to C$245.00 and gave the stock a "buy" rating in a report on Thursday, July 31st. Four investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of C$221.43.
Get Our Latest Stock Report on KXS
Kinaxis Stock Performance
Shares of KXS stock traded up C$1.95 on Friday, hitting C$183.54. 28,035 shares of the stock were exchanged, compared to its average volume of 73,168. Kinaxis has a one year low of C$149.96 and a one year high of C$212.45. The company has a current ratio of 1.89, a quick ratio of 2.29 and a debt-to-equity ratio of 12.12. The firm has a market capitalization of C$5.19 billion, a PE ratio of 213.42, a P/E/G ratio of 3.60 and a beta of 0.93. The firm's 50 day moving average is C$191.48 and its two-hundred day moving average is C$188.53.
Insiders Place Their Bets
In related news, insider Mark Justin Morgan sold 2,281 shares of Kinaxis stock in a transaction on Friday, August 15th. The stock was sold at an average price of C$198.63, for a total value of C$453,081.87. Following the transaction, the insider directly owned 11,000 shares in the company, valued at C$2,184,963. The trade was a 17.17% decrease in their position. Also, insider Andrew William Robert Bell sold 275 shares of the company's stock in a transaction dated Thursday, August 21st. The shares were sold at an average price of C$193.18, for a total transaction of C$53,124.50. Following the transaction, the insider directly owned 1,919 shares of the company's stock, valued at C$370,712.42. This represents a 12.53% decrease in their position. Insiders sold 8,656 shares of company stock worth $1,665,206 over the last three months. 1.20% of the stock is owned by insiders.
Kinaxis Company Profile
(
Get Free Report)
Kinaxis Inc is a Canada-based provider of software solutions for sales and operations planning (S&OP) and supply chain management. The firm's flagship RapidResponse product is offered on the cloud. Its capabilities include consequence evaluation and alerting, responsibility-based collaboration, high-speed analytics, and scenario simulation.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Kinaxis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kinaxis wasn't on the list.
While Kinaxis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.